Acquired

XinThera Stock

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

Sign up today and learn more about XinThera Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About XinThera Stock

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

Funding History

2021-08-01$50.0M

Management

Board Member

Carl L. Gordon

Co-founder and Senior Vice President

Gene Hung

Board Member

Michael Rome

Co-Founder and Chairman

Stephen Kaldor

Board Member

Jim Tananbaum

President & CSO

Qing Dong

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo